Dabur India junks report about presence of cancer-causing substance in its honey
Terming the claim as "motivated" and "baseless", Dabur India Ltd has junked the report about the presence of cancer-causing substance in its honey and clarified that every batch of honey that the company produces, complies with FSSAI standards.
The Dabur Honey and Chyawanprash maker's revenue in April-June rose nearly 11% to 31.30 billion rupees, led largely by growth in its consumer care business. Honey products contribute 6–7% to Dabur's revenues in India.
For more details click on the given link:
'Honey' Trap? Dabur clarifies on presence of cancer causing chemicals in product, says report motivated, baseless
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd